Bagrov AY - Search Results

1

Acute salt loading and cardiotonic steroids in resistant hypertension.

Emelyanov IV, Konradi AO, Lakatta EG, Fedorova OV, Bagrov AY. Emelyanov IV, et al. Among authors: bagrov ay. Curr Top Membr. 2019;83:1-13. doi: 10.1016/bs.ctm.2019.01.005. Epub 2019 Feb 18. Curr Top Membr. 2019. PMID: 31196601 Free PMC article.

2

Endogenous marinobufagenin-like immunoreactive factor and Na+, K+ ATPase inhibition during voluntary hypoventilation.

Bagrov AY, Fedorova OV, Austin-Lane JL, Dmitrieva RI, Anderson DE. Bagrov AY, et al. Hypertension. 1995 Nov;26(5):781-8. doi: 10.1161/01.hyp.26.5.781. Hypertension. 1995. PMID: 7591018

3

Effects of two endogenous Na+,K(+)-ATPase inhibitors, marinobufagenin and ouabain, on isolated rat aorta.

Bagrov AY, Roukoyatkina NI, Pinaev AG, Dmitrieva RI, Fedorova OV. Bagrov AY, et al. Eur J Pharmacol. 1995 Feb 14;274(1-3):151-8. doi: 10.1016/0014-2999(94)00735-p. Eur J Pharmacol. 1995. PMID: 7768267

4

Effect of endogenous digoxin-like factor and digoxin antibody on myocardial Na+, K(+)-pump activity and ventricular arrhythmias in acute myocardial ischaemia in rats.

Bagrov AY, Fedorova OV, Roukoyatkina NI, Zhabko EP. Bagrov AY, et al. Cardiovasc Res. 1993 Jun;27(6):1045-50. doi: 10.1093/cvr/27.6.1045. Cardiovasc Res. 1993. PMID: 8221762

5

Endogenous digoxin-like factor in acute myocardial infarction.

Bagrov AY, Kuznetsova EA, Fedorova OV. Bagrov AY, et al. J Intern Med. 1994 Jan;235(1):63-7. doi: 10.1111/j.1365-2796.1994.tb01033.x. J Intern Med. 1994. PMID: 8283162

6

Digitalis-like and vasoconstrictor effects of endogenous digoxin-like factor(s) from the venom of Bufo marinus toad.

Bagrov AY, Roukoyatkina NI, Fedorova OV, Pinaev AG, Ukhanova MV. Bagrov AY, et al. Eur J Pharmacol. 1993 Apr 6;234(2-3):165-72. doi: 10.1016/0014-2999(93)90950-m. Eur J Pharmacol. 1993. PMID: 8387009

7

Plasma marinobufagenin-like and ouabain-like immunoreactivity during saline volume expansion in anesthetized dogs.

Bagrov AY, Fedorova OV, Dmitrieva RI, French AW, Anderson DE. Bagrov AY, et al. Cardiovasc Res. 1996 Feb;31(2):296-305. Cardiovasc Res. 1996. PMID: 8730407

8

Endogenous marinobufagenin-like immunoreactive substance. A possible endogenous Na, K-ATPase inhibitor with vasoconstrictor activity.

Bagrov AY, Dmitrieva RI, Fedorova OV, Kazakov GP, Roukoyatkina NI, Shpen VM. Bagrov AY, et al. Am J Hypertens. 1996 Oct;9(10 Pt 1):982-90. doi: 10.1016/0895-7061(96)00148-3. Am J Hypertens. 1996. PMID: 8896650

9

Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms.

Fedorova OV, Bagrov AY. Fedorova OV, et al. Among authors: bagrov ay. Am J Hypertens. 1997 Aug;10(8):929-35. doi: 10.1016/s0895-7061(97)00096-4. Am J Hypertens. 1997. PMID: 9270089

10

Characterization of a urinary bufodienolide Na+,K+-ATPase inhibitor in patients after acute myocardial infarction.

Bagrov AY, Fedorova OV, Dmitrieva RI, Howald WN, Hunter AP, Kuznetsova EA, Shpen VM. Bagrov AY, et al. Hypertension. 1998 May;31(5):1097-103. doi: 10.1161/01.hyp.31.5.1097. Hypertension. 1998. PMID: 9576120

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters